N
Google TrendELLIOT ANDERSON (200+) — James McAtee: How Oliver Glasner has transformed Nottingham Forest midfielder from forgotten man to his new Adam Wharton
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:elliot anderson200+sean young200+mayank yadav1000+tornado near me1000+pep guardiola500+virgil van dijk200+beşiktaş vs kocaelispor200+is zay flowers playing500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Optimizing Statin Therapy" (30 stories)

Top Headline Story

Optimizing Statin Adherence and Triglyceride Management in Clinical Practice
Lead StoryPharmacy Timesgeneral
Apr 12

Optimizing Statin Adherence and Triglyceride Management in Clinical Practice

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxNYVd2UkNsbzkyX1EzYnRBcGllMkV3TlhkYUpiUXlMM0VCWEQ2ZUdZOUF6bzRYQjhaVXR4ZmxES21SaGVXYkRGQ2JCWGthTXM0Vm5FNHNuTkxoZW0xUDRrMjFmWlluS1VMQ0hvNXNUTXVubUJZWnpFT19tSFdUdmFtZVBEeGV4UVVFX3phNU5jWTdHYUh0SUk5aF81T2pZLWI2cXliSUZiYmR2Q05LSTdRNg?oc=5" target="_blank">Optimizing Statin Adherence and Triglyceride Management in Clinical Practice</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+19m ago

elliot anderson

James McAtee: How Oliver Glasner has transformed Nottingham Forest midfielder from forgotten man to his new Adam Wharton

Filter stories
200+29m ago

sean young

Michael Douglas confirms Charlie Sheen put ‘c---’ sign on Sean Young during Wall Street shoot

Filter stories
1000+29m ago

mayank yadav

Gambhir: 'Bowlers' careers are at stake'

Filter stories
1000+39m ago

tornado near me

Tornado watches expire in SC; NWS tracked 2 confirmed tornadoes

Filter stories

Search Results for "Optimizing Statin Therapy"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
ACC Releases Pathway Optimizing Postpartum Care, Preventing Cardiovascular Risk
Drug Topicsgeneral

ACC Releases Pathway Optimizing Postpartum Care, Preventing Cardiovascular Risk

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPWGdGYlZpZ2VMM054T0lEVXozVXlzWXpjTHJmbE1ObmVkcllNejBRcmNhS2RlMW5BSzdaWG5FbmZlQU5Edk5jdmRLdnhiZVRIRUxIMnUzLTdhYWEzZXVOMDl4aXh2V2hRQVlhS0dLV0ZDems5OUhBVFVVRlVkS0drbHR1REJjZ0VIQ2lyMHZpVGNrUWxVVWUwb0FJOTV5c0RsZm55WU5waDhFZDBxWFNz?oc=5" target="_blank">ACC Releases Pathway Optimizing Postpartum Care, Preventing Cardiovascular Risk</a>  <font color="#6f6f6f">Drug Topics</font>

Read Full StoryMore like this
Why Starting With the Right Statin Dose Matters for High-Risk Patients
Pharmacy Timesgeneral

Why Starting With the Right Statin Dose Matters for High-Risk Patients

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxOcWEzLUpKMlA3X0NCTktNSHhxZTd5SWk4dTFmUkxNSGRrSWcwQy1IQkFkdEhyb25mdlc1YVQ4am9ZemJxWmpQTUdZUlE0TEc0ak5vNmthdkxGMGRodzVJZWk2V1hDNWxyU0s2cy1vQ01JNFQzSk0zX2plWWRIMF9SVnR2RWE0NWNJMEZFUnZsOFBmUVZ1QnVScThjUF9rM2lHTDhUejFZQ3o?oc=5" target="_blank">Why Starting With the Right Statin Dose Matters for High-Risk Patients</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Optimizing long term disease prevention with reinforcement learning: a framework for precision lipid control
Naturegeneral

Optimizing long term disease prevention with reinforcement learning: a framework for precision lipid control

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBtU0dnanhVUk9DbGtBTFVHWjBvOEdjenlXVE9IY2RsaW1jNEFCam5keGwzaXNYMTdTLVh2VllLWDlYaDh1clVkcGNYUVgtaDVPOUdYRlpPTjJHTjlhREpN?oc=5" target="_blank">Optimizing long term disease prevention with reinforcement learning: a framework for precision lipid control</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Optimizing Cholesterol Management Improves the Benefits of Percutaneous Coronary Intervention∗:
JACC Journalsgeneral

Optimizing Cholesterol Management Improves the Benefits of Percutaneous Coronary Intervention∗:

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1ScEk5d2o0UENuaHZoLUY1X2xlRnVmY0w2SEc4V3Nzc2FUcXM4QzFPMFg3WDlqaktBSUxSbVZ4NE44VzdIYkdGSFJJZGtiOHRxOVluQVpnNzQ4Wnc3Q3Z5LQ?oc=5" target="_blank">Optimizing Cholesterol Management Improves the Benefits of Percutaneous Coronary Intervention∗:</a>  <font color="#6f6f6f">JACC Journals</font>

Read Full StoryMore like this
Statin, Ezetimibe Therapy Combo Shows Promise for Reducing CVD Risk
U.S. Medicinegeneral

Statin, Ezetimibe Therapy Combo Shows Promise for Reducing CVD Risk

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxOUWhqQVFWYjFTWFFYTEJyajhKcnE2Q0t6NWxKbll4Njd5ZVJla0Nva1MtMnR4T1hOaEtSUjJsbHhzUDdPUnlKOG5jYXJ1Tm1HTWJSZWxMZlBrcFZRTW9DRGk4b2xWeXBpRGpDSFltM2Q4OUNJWGJEZXBmQUpnQnlkWlAwRV9pT3B6bmRFVGFxMjBIek51LXZYVzJncVh5MHpZMG05d0pmeFhrTmtnRlNIUFVOQlkwMTZxSEwxRWNUdFdoSWllVjlvTTZ4ZlZmQQ?oc=5" target="_blank">Statin, Ezetimibe Therapy Combo Shows Promise for Reducing CVD Risk</a>  <font color="#6f6f6f">U.S. Medicine</font>

Read Full StoryMore like this
Adding Ezetimibe to High-Intensity Statin at the Time of Admission in Patients With Acute Coronary Syndrome: Results From the Optimization of Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome (OLA) Study
The Cureus Journal of Medical Sciencegeneral

Adding Ezetimibe to High-Intensity Statin at the Time of Admission in Patients With Acute Coronary Syndrome: Results From the Optimization of Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome (OLA) Study

<a href="https://news.google.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?oc=5" target="_blank">Adding Ezetimibe to High-Intensity Statin at the Time of Admission in Patients With Acute Coronary Syndrome: Results From the Optimization of Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome (OLA) Study</a>  <font color="#6f6f6f">The Cureus Journal of Medical Science</font>

Read Full StoryMore like this
Dr. Michael Blaha on Detecting Heart Disease, Treatment Adherence, and Optimal Statin Therapy
DocWireNewsgeneral

Dr. Michael Blaha on Detecting Heart Disease, Treatment Adherence, and Optimal Statin Therapy

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPWHo0czliSklOM05tNFNMazY3TS1CRlNhcFVRREdzRnhqMVhhLTM4aXM0TGRMb25xOXlnOTJ6NzhRS1EwdHRTc2ozSnNXd1VzaDFGYS14dnVNbWxUWlZFYTR1cklWTW1DUU1kY3VtWTc3WEloeDlWS3VrcWJzTnVlMkcwTjhMNHQxZVd6UEVmNW9kZVRBdXhQZkxmNWtRYkt5N19iemZnNWZYRndQREhGZjdtNzhydndrRTlES2hVNXlleHc?oc=5" target="_blank">Dr. Michael Blaha on Detecting Heart Disease, Treatment Adherence, and Optimal Statin Therapy</a>  <font color="#6f6f6f">DocWireNews</font>

Read Full StoryMore like this
Guideline Updates and Optimizing Adherence in Post-ACS Lipid Management
Pharmacy Timesgeneral

Guideline Updates and Optimizing Adherence in Post-ACS Lipid Management

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOTGNBSzZ3ZmZvVkY5OW1LUG5HQzJna05rdG51R1ctQ0JHeW9UUW81RGR0QTdzcnhsUzVlWjU5UDJ4eGl4WkZmX2tLaDJQRV9CWEtqaFRjWUk5RVZ1M1h1V1ZWUUxqVXBvQUN0SFdwcDJXenZ0dzN4NF9tamJyQWRLeHBzcE0xX2txajR3ekNqdmJmTUhhVVpNMjBES09nQzZDSjVjUnR1LV9jZw?oc=5" target="_blank">Guideline Updates and Optimizing Adherence in Post-ACS Lipid Management</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease
ACP Journalsgeneral

Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease

<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTE5YQzNRT0k2Q1ppYmh5ak9sZ3o5QWcxdXVTR0VZV2RmVEpRNWZRdFpGeU54dkhaanJ1ckZvWHc3eTdtSDRnLTZESGMxcTdFRFhyNHp2ZlY3QXVJSjFBWU9pV2N2aUdad0c5M2FXMnJJVy0ydWhFb0E0WkJzaw?oc=5" target="_blank">Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease</a>  <font color="#6f6f6f">ACP Journals</font>

Read Full StoryMore like this
Breaking down barriers: How to optimize access, use of PCSK9 inhibitors
Healiogeneral

Breaking down barriers: How to optimize access, use of PCSK9 inhibitors

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOMkxwMl82VGEyR0hmRzEzakFZa2llQnp1b1FCMzNlMFoyUW8wTjNLUU5NNjJfbGZRU0xNQXliSk1VYk51RHFTempKZlhsTE01QURuYXA3cERxZ2RpWEt4cnNMTURvVkVpRVpSdFp1ZERUcDZfYjF2eHRncUNuNUxvZmRJYmk5TE5SVVRkczFlVm80TGoxaThFc2ZmOFhVMXRDMjVSSG9xbXNldWZ5ZnZPUVRTVGJXREd5?oc=5" target="_blank">Breaking down barriers: How to optimize access, use of PCSK9 inhibitors</a>  <font color="#6f6f6f">Healio</font>

Read Full StoryMore like this
Q&A: Intensive LDL Lowering and Cardiovascular Prevention Strategies, With Lawrence Leiter, MD
HCPLivegeneral

Q&A: Intensive LDL Lowering and Cardiovascular Prevention Strategies, With Lawrence Leiter, MD

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQeXZmYnl3c0o5N2ZBS29iY2pTRThvTEJndURhY0hEVkRKa1BkUDdTQTExZG02bzV6YjVpbzFTSGNNZkdpbUxEM0w0WEV1VGRhUjJCcWlOM3hyWjRfSGlsZml3TnZnVlZIa0JqUUppTXhScTFrbzg2dHVLYzdYVzc4N2ZWMmpmYVloQVB0MmtzSDBHWDlhX0dEZWY0aWlYa3VWWnZpTmRHN0xRQ29VR0Z2SXNRWndaZ1dlMkZYSw?oc=5" target="_blank">Q&A: Intensive LDL Lowering and Cardiovascular Prevention Strategies, With Lawrence Leiter, MD</a>  <font color="#6f6f6f">HCPLive</font>

Read Full StoryMore like this
Machine learning-based high-benefit approach versus traditional high-risk approach in statin therapy: the Shizuoka Kokuho database study
Naturegeneral

Machine learning-based high-benefit approach versus traditional high-risk approach in statin therapy: the Shizuoka Kokuho database study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBrVnR3bHgzbG01NWh4ME9Ud004TjUwRTNDLU85aFZrczZOVXNONnF2b2hCWmZoMWxtMDlnbnZIcHotdE1jaHJWMzFJUEdfWHVaS1VZOVdvdFJOaEdTUkJv?oc=5" target="_blank">Machine learning-based high-benefit approach versus traditional high-risk approach in statin therapy: the Shizuoka Kokuho database study</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Optimizing Post-ACS Management and Emerging LDL-C Lowering Strategies
Pharmacy Timesgeneral

Optimizing Post-ACS Management and Emerging LDL-C Lowering Strategies

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNMkJHQ2lfeVliUUd2RThNVnVhcE5WTjk1R1A5bDRRRUx1RXNGdnVwdGFNWGZlQmNhZkJaVlZaWUV0X21pMlI4NzdQYnFxN2RuX1lzWnNSbDFoZjJtVHhkcTREaHZpSXItZFJxMWhVbjBkYzYxb0s4WkZVVm5iMHF5d3Vrdjd5RkFJdGIzOEdXNHVkQkZIUnhfTjg4QmVKQ0theHNhT2s2VQ?oc=5" target="_blank">Optimizing Post-ACS Management and Emerging LDL-C Lowering Strategies</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Optimal Target Level of Low-density Lipoprotein Cholesterol for Vascular Function in Statin Naïve Individuals
Natureworld

Optimal Target Level of Low-density Lipoprotein Cholesterol for Vascular Function in Statin Naïve Individuals

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9HaTFjVWJyZTZHUlRMZjVkZUlYQXFrUjUzOTFnZ0tfSTBoamcyTWd6Y1g3MWtCVVh0akt1dFIxLTl1UFN0M3k3ZUdtcVFuZExaaDRFVVVuOTBmVHRvbUJ3?oc=5" target="_blank">Optimal Target Level of Low-density Lipoprotein Cholesterol for Vascular Function in Statin Naïve Individuals</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Optimal lipid-lowering therapy in patients who were functionally deferred percutaneous coronary intervention
Natureworld

Optimal lipid-lowering therapy in patients who were functionally deferred percutaneous coronary intervention

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9vakNJYzJVYnBnaEF0NWNoMnhNaXBDUTZrN0hpYkgtR3ZRR2U3OVlvWFZYZ09rejI2MUtNczB0LVk5UUpSY2Jna2dnTThBSnpONFQzdG9ianJqWHJYOFlB?oc=5" target="_blank">Optimal lipid-lowering therapy in patients who were functionally deferred percutaneous coronary intervention</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Optimizing Cholesterol Management: Incorporating Injectable Lipid-Lowering Therapies
Pharmacy Timesgeneral

Optimizing Cholesterol Management: Incorporating Injectable Lipid-Lowering Therapies

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNTE1wWkxXZ1VfbTA0clV6RTdkNlpOMkRvMEl3QUpCXy16N3RZeGFVN1B0bmh0R3BrSHhkNkJMc3U1YVBMWmxKQW5CcVJNcUtCa1JKcmNBeFlKMldJc2o1cGxZcl9vYmZHRmxUa3BYY1kzWnJpcWRKQlhaVEZ0a05DaVUxbEtXM2NiREp6VXBocTZENnliaHJ6bmRqM3VqTm93TGJTYTh1cmdXNHFpWDIyTFgyZ21FakVWaXc?oc=5" target="_blank">Optimizing Cholesterol Management: Incorporating Injectable Lipid-Lowering Therapies</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Optimizing Statin Therapy by Avoiding Clinically Relevant Drug Interactions
Pharmacy Timesgeneral

Optimizing Statin Therapy by Avoiding Clinically Relevant Drug Interactions

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE9pN19OUmdJOEVYaU5keDJxZmVUQWFjaWItSHFYVDFtaXN0U3JpTW45WXljQkV1SlVvaVNtb3E3VGptOWgzb2Y4YkFCTE5PWEtyWTduZlE3X3R5TnVNeHc?oc=5" target="_blank">Optimizing Statin Therapy by Avoiding Clinically Relevant Drug Interactions</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Evolocumab, Optimized Statin Therapy Improve Plaque Stability in Patients With Coronary Artery Disease
Pharmacy Timesgeneral

Evolocumab, Optimized Statin Therapy Improve Plaque Stability in Patients With Coronary Artery Disease

<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxPNG1NS3hKbTBDd1Y4SnNDbnRCYmZTRGd2aDNfNnBVbEQyWWZROF9kUVBlWEpGSlJOTy1BbS1ockhVVTNScGtKWWt1UjBtRTM2dzBoUm5HYzhGcml3bk1wcmtHUGd0Y1lYWVVwbEV0TlFoVlhWM0xCZUgzVTgxQ0NmUEpUd3hqeUMzQloya1B3X3g5aHFHTUxCWjFuUkV3TEpxLTAtQ3Q0TWlyRG16OFJodkdDMG9YZTRQLTlGNGtudng2cFI0VlhpQlY5OEtMUGVwQVE?oc=5" target="_blank">Evolocumab, Optimized Statin Therapy Improve Plaque Stability in Patients With Coronary Artery Disease</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Highlights From NLA 2025: Early LDL-C Reduction and Emerging Therapies
Pharmacy Timesgeneral

Highlights From NLA 2025: Early LDL-C Reduction and Emerging Therapies

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNWlRuUDhvVzNQUmNjN3NWdkd0MWRBZFM4Zkt2RE1JbDlnMkwzSS1VU0lsTW1SWFgyUjVJdHdpaUxmRUhabXo5dFB1MGJNX08zbDJQa2RqY2J6VUpUaGZ2TnktcWp2ODZEd2VuenJCZ1lOS09GcjhOdFplNXJvYWxKckgxY195NS1WRE15WTNLMUtnNnZkTnZUdVFzaEd5NzhidUlibzRTbw?oc=5" target="_blank">Highlights From NLA 2025: Early LDL-C Reduction and Emerging Therapies</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Hyperlipidemia: Effective Disease Management With a Focus on PCSK9 Inhibitors
AJMCgeneral

Hyperlipidemia: Effective Disease Management With a Focus on PCSK9 Inhibitors

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQMGVTLXAyZkVvNUFydDJlN1NES2RBT0JyUjB1MGhlWDB6SWxpOVhYMnB2U0FGdDRRUnJEeWI0bzJXaTg3VG9EVm1JWmE5MDlKMzVOcFlPRjk4VHFpZ0dWOHh6VmJKRFc5Tjk5QW5IMlZ5dlVPekpoUHc0MDZCZXlUU01lX3oyQi1RNTYzTGpFV0FBRmtFekVHU25KajBTVUFsb1JVMQ?oc=5" target="_blank">Hyperlipidemia: Effective Disease Management With a Focus on PCSK9 Inhibitors</a>  <font color="#6f6f6f">AJMC</font>

Read Full StoryMore like this
Finding the Optimal Statin Dose
The American Journal of Managed Caregeneral

Finding the Optimal Statin Dose

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE16LWxNQVFUaGV2a2pqWElCSlMtZ3dWYWxhaTNfa1EwNzVzTHRrdk9taVN4WjZhRS1CX1VkZjdxNXBGaC1OVEdPUXVNMmQwdG0tNUUxUUJ5NE5KMnNabklJRDdqMXUyQW1Z?oc=5" target="_blank">Finding the Optimal Statin Dose</a>  <font color="#6f6f6f">The American Journal of Managed Care</font>

Read Full StoryMore like this
Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome
American Heart Association Journalsgeneral

Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE1aUU1YRWlUOFhjaUo5OTJuRXFoejQ1TDlvejFTMHl3S3l4aWJmaXJ5U19RZlY1MjdXaE5oVmN3cXR1cHFFUW1OdmZadG1yZ1pqQVlQRGY5ZHJHZjgxWGgtb1hja1lvS1BzemxrWFRmOFRrVkE?oc=5" target="_blank">Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Read Full StoryMore like this
Optimizing Lipid Control for Lower Extremity Peripheral Artery Disease
The Cardiology Advisorgeneral

Optimizing Lipid Control for Lower Extremity Peripheral Artery Disease

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOZlFaZzl3WjlrTGpOdEwzSE1mdUFWR2VVeWxmcE1PY3J6cUdqMjZ0YXl3eldFb01jT1NTTnB2MldQOUhMZU9Ucmw2V2lEcmF3SkRSb0RQOTFSc0VUdWJqYmI0QzAyUnNOVW4tNTNDSW5pRFczcWFNaEpDYW1BVWhfcUVkMWZJbk1DSGZuZjFKZjQyUkVucGo0SUJwNmlpZ08yd2NSSUZIWHFYSjlHOTlMU3R3c2wyLS1Z?oc=5" target="_blank">Optimizing Lipid Control for Lower Extremity Peripheral Artery Disease</a>  <font color="#6f6f6f">The Cardiology Advisor</font>

Read Full StoryMore like this
Business of Medicine | Lowering LDL-C to ‘Transform’ ACS Outcomes
American College of Cardiologygeneral

Business of Medicine | Lowering LDL-C to ‘Transform’ ACS Outcomes

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNN1IxdFhmNkQ0N09OeWlxeWxUb1U4dExHWmxhcm8wYjByNl9iY0RJS1lFRFg4LTB3MHJYOUFGOWFlYVlzMi1ZdXpfUXlJdWpuc0FRRm9ETm5rcEJtVy1iQXJJX2x5LXNqQ093TG1SQXdJZ1o5RmZ4Q1RyLUE0cVpVbkpvREVUT1cteER6M09TQ0pkWUplN0pSSXlEdG1sZ2Y5NXpjOHJfUHJSSlFNLUhwRFNMa0k1M1BTdm5jcVBXd1FacHVKSFdR?oc=5" target="_blank">Business of Medicine | Lowering LDL-C to ‘Transform’ ACS Outcomes</a>  <font color="#6f6f6f">American College of Cardiology</font>

Read Full StoryMore like this
The role of statins in the regulation of breast and colorectal cancer and future directions
Frontiersgeneral

The role of statins in the regulation of breast and colorectal cancer and future directions

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQWk9oSnE3VTJSTDdYaUFqakt6ZzdqS0NGZm1XNjRwWG1RR0NOWWstX25YaFJSZ1pucVZNNWlfdThxcHEwSnRURXF2bGRkbG9HdkltYVQzNzVaN21adFJldzFTSWhRZExUdEZ5a2dCTHJkanJsWllDakN4ci1wN3lJdHRNWV9HX0oxeDlwSDVzWWgwMXJO?oc=5" target="_blank">The role of statins in the regulation of breast and colorectal cancer and future directions</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Trends in prescribing optimal medical therapy at discharge following percutaneous coronary intervention in a tertiary care hospital in the UAE
Frontiersgeneral

Trends in prescribing optimal medical therapy at discharge following percutaneous coronary intervention in a tertiary care hospital in the UAE

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxOOVMtM08tWWRyOGVaQVh3Ny1KdnFyNHp4VDl2Q05qSmxXaGU5Rk9YSW1TeWpVUnZTY1N1RFAxT3c2R1d3c2pCYUUwcnhFbV9QRHFrNUNhRFVETi14bF9LanJDZi1TZWJtLUxEd2dGWlVkYUd0dnZIOHlranZmQ2lDbFpxdWQ4aS1abTExbzdNNXVtX05NYWxhU1hybDR5VF9nb0E?oc=5" target="_blank">Trends in prescribing optimal medical therapy at discharge following percutaneous coronary intervention in a tertiary care hospital in the UAE</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Steve Nissen, MD: Optimizing Lp(a) Management by Learning from Missteps with LDL-C
HCPLivegeneral

Steve Nissen, MD: Optimizing Lp(a) Management by Learning from Missteps with LDL-C

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOVnNQYWZuUEdSNlhpRDFHYi1NenJMTkhkb2tPR0ZjRzNocEhEeDFWV0JONXQxZnZvaWdxSmwzY09VNnMtcDRmdnRKRExHMllXVGRMWVVEeWpESTFIektPSzhhbmNkeHp2QjVFRU5HaldkX0lmSGJ2QVluR25tbHZXN1UyWHdxXzhGMWhvX0Y5ZFB4UklvbnRxRTNXUnVVNkI4MnpfTEFRaUdHaTky?oc=5" target="_blank">Steve Nissen, MD: Optimizing Lp(a) Management by Learning from Missteps with LDL-C</a>  <font color="#6f6f6f">HCPLive</font>

Read Full StoryMore like this
QSAR and scaffold-based optimization of HMGR inhibitors using cheminformatics and machine learning
Frontiersgeneral

QSAR and scaffold-based optimization of HMGR inhibitors using cheminformatics and machine learning

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQNWxEUmlrNjdSZkVvSlpHWlR0LVlpU1cyUzZvbUhlVGY4T2FHbVJSekM4Z3p6U3J0LWttSTlwUjhGRC1aR1VxVzdhbE5FT3RPQzN6c0RKcFI5aW1YRHA4SVlJRWFnMFVLTmdYOE1qZ0ZZWjRhNFFvTjhDbjh4eEdMTkpRNXBvejFGcS1yVTl4Rk5qUjRZVDRz?oc=5" target="_blank">QSAR and scaffold-based optimization of HMGR inhibitors using cheminformatics and machine learning</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
How Nonstatin Therapies Can Optimize Patients’ Cardiovascular Health | ASHP Midyear
Drug Topicsscience

How Nonstatin Therapies Can Optimize Patients’ Cardiovascular Health | ASHP Midyear

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQNjJQT0dSNk9IVFZKSTZraU5ESktYSURuWEhHRTZERjZ0eW1BTUVvRTFBVFV0cDlQWnFJRFZUU3VjTGxVTzBUT1Y2amZ0VW9la3VBT1lBeWZXU2FvUFU3cU5LWU1HZUpESXJzaUdwT1BCQ1VfUkFNa29ub2hFNTZPVTlJa2t4NUhxZHl0OHBHUUtGTlBnck5oTDQyTDZ0TE82?oc=5" target="_blank">How Nonstatin Therapies Can Optimize Patients’ Cardiovascular Health | ASHP Midyear</a>  <font color="#6f6f6f">Drug Topics</font>

Read Full StoryMore like this
"Optimizing Statin Therapy" — Live Google News Trends & Headlines